REPORT AND RECOMMENDATION

G.R. SMITH, Magistrate Judge.

Having pled guilty to, and been sentenced for, being an illegal alien in possession of a firearm and for carrying a firearm during and in relation to a drug trafficking crime, (doc. 144 (plea agreement)1, doc. 145 (judgment) (entered January 23, 2014)), Juan Zapien-Pacheco moves under 28 U.S.C. § 2255 to vacate his carrying conviction. Doc. 34. Preliminary review under Rule 4 of the Rules Governing Section 2255 Proceedings shows that his motion must be denied.

After the Court sentenced him to 100 months' imprisonment (doc. 145), Zapien-Pacheco never appealed. His conviction thus became final on February 6, 2014. Fed. R. App. P. 4(b)(1)(A) (criminal defendants must file a notice of appeal within 14 days of the entry of judgment). He filed the instant § 2255 motion almost two years later. Doc. 240 at 2 (filed June 14, 2016). In it he argues that Johnson v. United States, ___ U.S. ___, 135 S.Ct. 2551 (2015), voids his 18 U.S.C. § 924(c) conviction for carrying a firearm during and in relation to a drug trafficking crime. Doc. 240 at 3.

The Armed Career Criminal Act ("ACCA") — the statute Johnson addressed — provides enhanced penalties for defendants who are (1) convicted of being felons in possession of firearms in violation of 18 U.S.C. § 922(g) and (2) have "three prior convictions . . . for a violent felony or a serious drug offense, or both." It defines "violent felony" as, among other things, a felony that "otherwise involves conduct that presents a serious potential risk of physical injury to another." Id. at § 924(e)(2)(B). Johnson found that "residual" clause so vague as to violate due process. See 135 S. Ct. at 2557. Importantly, it said nothing about "serious drug offenses," which remain a valid basis for ACCA enhancements. See id. at 2563 ("Today's decision does not call into question application of the Act to the four enumerated offenses, or the remainder of the Act's definition of a violent felony," much less its definition of "serious drug offense").

Even assuming it applies at all to § 924(c),2 Johnson provides Zapien-Pacheco no succor here. Under § 924(c), a person cannot use or carry a firearm during or in relation to "any crime of violence or drug trafficking crime." 18 U.S.C. § 924(c)(1)(A) (emphasis added). Although one clause of its crime of violence definition reads similarly to ACCA's residual clause (and thus Johnson's logic may well apply), Zapien-Pacheco committed a drug trafficking offense.

As the Government aptly put it, "Johnson has no conceivable application in that context." Doc. 244 at 3. That's because Johnson says nothing about the viability of "serious drug offense"3 predicates. See 135 S. Ct. at 2563. The term "drug trafficking crime" in § 924(c)(1)(A) covers similar ground as that ACCA phrase.4 And just as Johnson's logic failed to implicate drug offenses in the ACCA context, so too does it not apply to "drug trafficking crimes" for purposes of § 924(c).

It follows that Zapien-Pacheco cannot look to Johnson and § 2255(f)(3) to define when his one-year statute of limitations began to run. Instead, he's relegated to § 2255(f)(1), which dictates that the clock started the day his conviction became final (February 6, 2014). His time to file for § 2255 relief thus expired on February 6, 2015, so his motion is untimely by well over a year (he did not file it until June 14, 2016, doc. 240 at 2).5

Accordingly, Juan Zapien-Pacheco's § 2255 motion should be DENIED. Applying the Certificate of Appealability (COA) standards set forth in Brown v. United States, 2009 WL 307872 at * 1-2 (S.D. Ga. Feb.9, 2009), the Court discerns no COA-worthy issues at this stage of the litigation, so no COA should issue either. 28 U.S.C. § 2253(c)(1); Rule 11(a) of the Rules Governing Habeas Corpus Cases Under 28 U.S.C. § 2255 ("The district court must issue or deny a certificate of appealability when it enters a final order adverse to the applicant.") (emphasis added). Any motion for leave to appeal in forma pauperis therefore is moot.

SO REPORTED AND RECOMMENDED.